| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
7e-05 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0007 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |